Levonorgestrel-releasing intrauterine system: why do some women dislike it?
Suzanna Daud1, Ayman A A Ewies
1Department of Gynaecology, The Ipswich Hospital NHS Trust, Ipswich, Suffolk, UK.
Background:
There is growing evidence of women's dissatisfaction with the levonorgestrel-releasing intrauterine system (LNG-IUS) because of a high incidence of adverse effects.
Objective:
To quantify the continuation rate and users' satisfaction, and identify symptoms associated with early removal before the 5-years effective life-time.
Method:
A questionnaire was sent to 212 women, who had LNG-IUS inserted from 1 January 1998 to 31 December 2003 at The Ipswich Hospital, UK.
Results:
The response rate was 76% (n = 161), 16 of the respondents were excluded and the data of 145 are presented. The continuation rate was 85%, 70%, 59%, 56%, 50% and 50% at 6 months, 1, 2, 3, 4 and 5 years, respectively. The total number of women who had the LNG-IUS removed before 5 years was 72 (50%), and the median duration of use was 270 days (range 4-1460). The reasons for early removal were unscheduled bleeding, progestogenic adverse effects, abdominal pain and others in 40 (28%), 32 (22%), 19 (13%) and 19 (13%) women, respectively. Only 73 (50%) women were satisfied with LNG-IUS.
Conclusions:
Our findings are similar to recent reports, and this information should be readily available to women to enable them to make an informed choice.
More Related Videos
Related Concept Videos
Intrauterine Drug Delivery Systems
Birth Control Methods
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Modified-Release Drug Delivery Systems: Overview
Oral Drug Delivery Systems: Continuous-Release Systems
Drugs for Treatment of Constipation-Predominant IBS


